New neuroplastogen: phase 1b shows no psychotomimetic effects
Posted by hank_m in Cognitive & Nootropic - 1 points, 0 comments.
The article reports that a first‑phase study of a new neuroplastogen developed by delix therapeutics found no evidence of psychotomimetic, hallucinatory, or dissociative effects in a small group of volunteers. The authors highlight the compound’s potential to promote neural plasticity without the side‑effects that sometimes accompany other cognitive enhancers.
I’m a bit excited but cautious. I’ve used a few peptides with mixed results, and when a new candidate claims “no mind‑bending side effects” it raises eyebrows. The study size was tiny and the duration short, so i question whether the safety profile will hold up in larger, longer trials. I’ve seen substances that started out promising but flared up later. This article gets no mention of cognitive outcomes or any objective performance data, which makes it hard to gauge the real benefit versus just a clean safety slate.
Do you think a compound that can safely increase plasticity without side effects could personalizada a new class of nootropics, or will the hype outpace the data?
Community discussion - research and educational context only. Not medical advice.